share_log

聖諾醫藥-B(02257.HK)首席戰略官辭任

AASTOCKS ·  May 19 21:37

聖諾醫藥-B(02257.HK)公布,戴曉暢由於個人理由辭任首席戰略官一職,自上周五(17日)起生效。戴曉暢將繼續擔任執行董事,並同意出任藥物開發和商業化高級顧問。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment